Peripheral and Central Pathological Mechanisms of Chronic Low Back Pain: A Narrative Review
Wei Li,Yinan Gong,Jingyi Liu,Yongming Guo,Huiling Tang,Siru Qin,Yadan Zhao,Songtao Wang,Zhifang Xu,Bo Chen
DOI: https://doi.org/10.2147/JPR.S306280
IF: 2.8319
2021-05-27
Journal of Pain Research
Abstract:Wei Li, 1 Yinan Gong, 1 Jingyi Liu, 1 Yongming Guo, 1– 3 Huiling Tang, 1 Siru Qin, 1 Yadan Zhao, 1 Songtao Wang, 1 Zhifang Xu, 1– 3 Bo Chen 1– 3 1 Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China; 2 School of Acupuncture & Moxibustion and Tuina, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, People's Republic of China; 3 National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, 300381, People's Republic of China Correspondence: Zhifang Xu School of Acupuncture & Moxibustion and Tuina, Tianjin University of Traditional Chinese Medicine, No. 10 Poyang Lake Road, Tuanbo New Town, Jinghai District, Tianjin, 301617, People's Republic of China Tel +86-22-5959-6290 Fax +86-22-2748-5189 Email Bo Chen School of Acupuncture & Moxibustion and Tuina, Tianjin University of Traditional Chinese Medicine, No. 10 Poyang Lake Road, Tuanbo New Town, Jinghai District, Tianjin, 301617, People's Republic of China Tel +86-22-5959-6290 Fax +86-22-2748-5189 Email Chronic low back pain (CLBP), lasting > 3 months, is the end result of multiple pathogenic factors. Unfortunately, little is known about CLBP pathogenesis, which limits its advancements in clinical therapy and disease management. This paper summarizes the known pathological axes of CLBP, involving both peripheral and central systems. In particular, this paper details injurious nerve stimulation, inflammation-induced peripheral pathway, and central sensitization. Lumbar components, such as intervertebral disc (IVD), facet joints, muscles, fascia, ligaments, and joint capsules, contain pain receptors called nociceptors. Degeneration of the aforementioned lumbar components activates inflammatory pathways, which can directly damage nerves, lower nociceptor threshold to fire action potentials (AP), and cause pain. Additionally, damaged lumbar IVDs and endplates can also lead to the pathologic invasion of nerve growth and innervation, followed by the compression of herniated IVDs on nerve roots, thereby causing traumatic neuropathic pain. The central mechanism of CLBP involves alteration of the sensory processing of the brain and malfunction of the descending pain modulatory system, which facilitates pain amplification in the center nervous system (CNS). Lastly, abnormalities in the brain biochemical metabolism, activation of glial cells, and subsequent inflammation also play important roles in CLBP development. Taken together, inflammation plays an important role in both peripheral and central sensitization of CLBP. Due to the heterogeneity of CLBP, its pathological mechanism remains complex and difficult to understand. Therefore, it is a worthy field for future research into the subcomponents of CLBP pathogenesis, in order to distinguish the specific form of the disease, identify its origins, and develop corresponding highly effective comprehensive therapy against CLBP. Keywords: chronic low back pain, inflammation, degeneration, nerve innervation, central sensitization Low back pain (LBP) refers to pain, muscle tension, or stiffness that occurs below the costal margin and above the inferior gluteal fold, with or without sciatica (pain that spreads from the lower back down to the legs). LBP persisting >3 months is termed as chronic low back pain (CLBP) and is no longer considered a symptom, but a disease caused by numerous onset factors and one that continues to progress. 1 LBP is one of the most common musculoskeletal diseases among people with chronic pain, and 45–75% of patients report feeling pain 12 months after the onset of LBP. 2 Till now, no satisfactory treatments exist for LBP. A systematic review of current evidences for CLBP treatment suggests that more research is needed to fully recognize the best choice of drugs, the best drug combination, and the best sequence of treatments for treating CLBP. 3 Although opioid analgesics are commonly used, their clinical benefits in the treatment of CLBP remain uncertain, and there is no evidence to support long-term use of any dose of opioid analgesics in the treatment of LBP. 4 The efficacy evaluation of non-steroidal anti-inflammatory COX-2 inhibitor and antidepressant duloxetine in the treatment of LBP is also controversial, as it can relieve short-term pain in some patients but has little impact on the overall improvement of back function. 5 Many non-drug therapies such as exercise therapy, tai chi, yoga, psychotherapy, spinal ma -Abstract Truncated-
clinical neurology